Hwan S. Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation.
Journal: Cardiovascular research
Published: January 27, 2025
PCSK9 stimulates Syk, PKCδ, and NF-κB, leading to atherosclerosis progression independently of LDL receptor.
Journal: Nature communications
Published: October 05, 2022
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.
Journal: European heart journal
Published: December 10, 2018
Priming mobilized peripheral blood mononuclear cells with the "activated platelet supernatant" enhances the efficacy of cell therapy for myocardial infarction of rats.
Journal: Cardiovascular therapeutics
Published: May 24, 2016
Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: March 19, 2014
Human podoplanin-positive monocytes and platelets enhance lymphangiogenesis through the activation of the podoplanin/CLEC-2 axis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 30, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026